Ingersoll Rand (NYSE: IR) announced strong Q4 2025 results, with low single-digit organic order growth and a return to organic revenue growth, exceeding prior guidance for adjusted EBITDA and EPS. The company highlighted robust inorganic growth through 16 acquisitions in 2025, and provided a 2026 full-year outlook expecting 2.5%-4.5% revenue growth and approximately 5% adjusted EPS growth at the midpoint. Management discussed ongoing market trends, strategic investments, and the positive momentum in recurring revenue and life sciences.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Ingersoll Rand Inc. (NYSE:IR) Q4 2025 Earnings Call Transcript
Ingersoll Rand (NYSE: IR) announced strong Q4 2025 results, with low single-digit organic order growth and a return to organic revenue growth, exceeding prior guidance for adjusted EBITDA and EPS. The company highlighted robust inorganic growth through 16 acquisitions in 2025, and provided a 2026 full-year outlook expecting 2.5%-4.5% revenue growth and approximately 5% adjusted EPS growth at the midpoint. Management discussed ongoing market trends, strategic investments, and the positive momentum in recurring revenue and life sciences.